UNSPSC 51293016: Noxiptiline hydrochloride

This classification denotes an antidepressant agent C19H22N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PNW59W2B94, chemically known as 5h-dibenzo(a,d)cyclohepten-5-one, 10,11-dihydro-, o-(2-(dimethylamino)ethyl)oxime, monohydrochloride, but more generally known as noxiptiline hydrochloride, which bears US NIH Compound Identifier 21086. European Medicines Agency schedules Noxiptiline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03469MIG.

Most nations, for tariff and trade purposes, schedule noxiptiline hydrochloride under HS 29280090 and SITC 51486. As of Q4 2014, NOXIPTILINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCON=C1C2CCCCC2CCC3C1CCCC3.CL.

UNSPSC 51293016 Noxiptiline hydrochloride is a Commodity code with minimal recent state and local procurement activity directly matching its scope. The single representative opportunity on record—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—concerns naloxone procurement for community health initiatives, not noxiptiline specifically. The county sought 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Two additional opportunities posted under this code—Texas Health and Human Services Commission's Therapeutic Pharmacy Initiative RFI and Minnesota Multistate Cooperative Purchasing Alliance's generic multi-source pharmaceuticals RFP—address pharmaceutical procurement broadly but do not reference noxiptiline or related agents. The code shows limited targeted demand at the state and local level.

Geographic activity centers on Florida (Seminole County) and multistate cooperative purchasing vehicles (Texas HHS and Minnesota MMCAP serving Oregon and other participating jurisdictions), but the opportunities posted under this code do not demonstrate sustained procurement of noxiptiline hydrochloride itself. Issuing bodies include county health departments, state health and human services agencies, and multistate cooperatives. The Seminole County IFB, posted June 30, 2026, with a response deadline of July 26, 2023, represents the closest match to pharmaceutical commodity procurement, but its focus on naloxone and deactivation systems rather than noxiptiline suggests the code assignment may not reflect actual purchasing intent. Without corroborating opportunities specifically naming noxiptiline hydrochloride, the code presents limited pursuit signal for vendors in this product line.